RWPA
GSK icon

Richard W. Paul & Associates’s GSK GSK Stock Holding History

Richard W. Paul & Associates’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-341
Closed -$16.7K – 304
2025
Q4 		$16.7K Sell
341
-79
-19% -$3.69K 0.01% 206
2025
Q3 		$18.1K Sell
420
-13
-3% -$508 0.01% 208
2025
Q2 		$16.6K Buy
+433
New +$16.5K 0.01% 224

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Richard W. Paul & Associates's GSK Position: Q1 2026 in Review

Richard W. Paul & Associates sold out of GSK (GSK) in Q1 2026, closing a stake of 341 shares — an estimated $16.7K sold.

Richard W. Paul & Associates first reported a position in GSK in Q2 2025 and held it in 3 quarters. The position peaked at $18.1K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Richard W. Paul & Associates reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Richard W. Paul & Associates sold 341 GSK shares in Q1 2026, an estimated $16.7K.
  • Richard W. Paul & Associates first reported a position in GSK in Q2 2025 and held it in 3 quarters.
  • Richard W. Paul & Associates's GSK position peaked at $18.1K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Richard W. Paul & Associates's 13F filing for Q1 2026, filed 13 May 2026.